AnaptysBio Inc旗下First Tracks Bio将于2026年4月6日启动纳斯达克"Trax"代号"暂缓交易"

美股速递
Mar 27

AnaptysBio Inc宣布,其旗下公司First Tracks Bio已获得纳斯达克交易所批准,将于2026年4月6日正式启动股票"暂缓交易"(When-Issued Trading),交易代码定为"Trax"。这一重要进展标志着该公司资本化进程迈出关键一步,为后续正式上市奠定基础。

"暂缓交易"机制允许投资者在股票正式发行前进行有条件交易,为市场提供价格发现功能。此次First Tracks Bio选择该交易方式,反映出市场对其发展前景的积极预期。专业分析师指出,此类交易安排通常预示着企业即将进入资本市场的实质性阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10